The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II neoadjuvant trial of albumin-bound paclitaxel, trastuzumab and pertuzumab followed by anthracycline based regimens in patients with operable HER2 positive breast cancer (OMC-BC05).
 
Mitsuhiko Iwamoto
No Relationships to Disclose
 
Ayana Ikari
No Relationships to Disclose
 
Tomo Tominaga
No Relationships to Disclose
 
Saki Maezawa
No Relationships to Disclose
 
Junna Sakane
No Relationships to Disclose
 
Hiroyo Oku
No Relationships to Disclose
 
Katsuhide Yoshidome
No Relationships to Disclose
 
Takashi Morimoto
No Relationships to Disclose
 
Hiroya Fujioka
No Relationships to Disclose
 
Seita Hagihara
No Relationships to Disclose
 
Toshikatsu Nitta
No Relationships to Disclose
 
Ayumi Matsutani
No Relationships to Disclose
 
Kosei Kimura
No Relationships to Disclose